Clover Health Investments, Corp. (NASDAQ:CLOV) saw a 19.37% surge in stock price on Friday, closing at $3.82 per share after receiving a “buy” recommendation from an investment firm. Zacks Research upgraded CLOV to “buy” due to an upward trend in earnings estimates, predicting an earnings per share of $0.10 for fiscal year 2025.

Analysts have been increasing their estimates for Clover Health Investments, Corp. (NASDAQ:CLOV), with the Zacks Consensus Estimate rising by 25% over the past three months. The company is set to release its third quarter financial results on November 6, 2025, adding further anticipation to its performance in the market.

While CLOV shows promise as an investment, some AI stocks are viewed as having greater potential for higher returns with limited downside risk. Investors seeking an inexpensive AI stock with significant growth potential can refer to a free report on the best short-term AI stock, highlighting its benefits amidst changing market dynamics.

Read more at Yahoo Finance: Clover Health (CLOV) Jumps 19.4% on “Buy” Reco